[go: up one dir, main page]

PT969827E - Mistura de acidos gordos primarios obtida a partir de cera de cana de acucar - Google Patents

Mistura de acidos gordos primarios obtida a partir de cera de cana de acucar

Info

Publication number
PT969827E
PT969827E PT98920719T PT98920719T PT969827E PT 969827 E PT969827 E PT 969827E PT 98920719 T PT98920719 T PT 98920719T PT 98920719 T PT98920719 T PT 98920719T PT 969827 E PT969827 E PT 969827E
Authority
PT
Portugal
Prior art keywords
mixture
fatty acids
sugar cane
acids obtained
cane wax
Prior art date
Application number
PT98920719T
Other languages
English (en)
Inventor
Abilio Laguna Granja
Luis Gonzales Bravo
David Marrero Delange
Rosa Maria Mas Ferreiro
Maria De Lourdes Arruz Valmana
Daysi Carbajal Quintana
Mirian Cora Medina
Roberto Menendez Soto De Valle
Original Assignee
Dalmer Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalmer Lab Sa filed Critical Dalmer Lab Sa
Publication of PT969827E publication Critical patent/PT969827E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
PT98920719T 1997-04-02 1998-04-01 Mistura de acidos gordos primarios obtida a partir de cera de cana de acucar PT969827E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997035A CU22723A1 (es) 1997-04-02 1997-04-02 Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos

Publications (1)

Publication Number Publication Date
PT969827E true PT969827E (pt) 2003-07-31

Family

ID=5459247

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98920719T PT969827E (pt) 1997-04-02 1998-04-01 Mistura de acidos gordos primarios obtida a partir de cera de cana de acucar

Country Status (19)

Country Link
US (1) US6486205B2 (pt)
EP (1) EP0969827B1 (pt)
JP (2) JP4907750B2 (pt)
CN (1) CN1230158C (pt)
AR (1) AR016054A1 (pt)
AT (1) ATE233087T1 (pt)
AU (1) AU732045B2 (pt)
BR (1) BR9808470A (pt)
CA (1) CA2285242C (pt)
CO (1) CO4940484A1 (pt)
CU (1) CU22723A1 (pt)
DE (1) DE69811643T2 (pt)
DK (1) DK0969827T3 (pt)
ES (1) ES2192769T3 (pt)
MY (1) MY120318A (pt)
PT (1) PT969827E (pt)
RU (1) RU2217130C2 (pt)
WO (1) WO1998043631A1 (pt)
ZA (1) ZA982744B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4666705B2 (ja) * 1999-12-07 2011-04-06 三井製糖株式会社 消化管潰瘍予防剤または改善剤
US20030203854A1 (en) * 2002-04-23 2003-10-30 Ivo Pischel Composition for effecting serum cholesterol levels
EP1515714B1 (en) * 2002-06-17 2009-08-12 Medestea Research & Production S.p.A. Long chain unsaturated oxygenated compounds and their use in the therapeutical, cosmetic and nutraceutical field
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20060013842A1 (en) * 2004-07-15 2006-01-19 Matkin John R Natural mixture of long-chain fatty alcohols and long-chain fatty acids, its obtension from animal and vegetable waxes and its nutraceutical uses
US7542034B2 (en) * 2004-09-23 2009-06-02 Conversion Works, Inc. System and method for processing video images
KR100723950B1 (ko) * 2005-01-04 2007-05-31 주식회사 하이폭시 벼과 식물 추출물을 포함하는 허혈성 질환 및 퇴행성뇌질환의 예방 및 치료를 위한 조성물
KR100685681B1 (ko) * 2005-07-26 2007-02-26 전북대학교산학협력단 수수에서 폴리코사놀 또는 옥타코사놀 함량이 높은긴사슬지방을 제조하는 방법
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
US20070295326A1 (en) * 2006-06-07 2007-12-27 Rafael Almagro Method for obtaining long chain aliphatic alcohols and fatty acids from sugar cane mud and related wax esters
US20080207748A1 (en) * 2007-02-22 2008-08-28 Innovation Labs, Inc. Vitamin c preparation
DE102010052789A1 (de) * 2010-11-27 2012-05-31 Wachs-Chemie Elsteraue E.K. Herstellung und Reinigung von PC-Wachs und deren technische Anwendungen
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102429853B1 (ko) * 2017-11-30 2022-08-05 (주)아모레퍼시픽 천연 왁스를 이용한 지방산 조성물 제조방법 및 그에 따라 제조된 지방산 조성물
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007329A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
CU24638B1 (es) * 2020-02-03 2023-01-16 Centro Nac De Investigaciones Cientificas Suspensión oral con efecto antiulceroso y quimioprotector sobre el cáncer de colon
CU24732B1 (es) * 2021-07-13 2025-02-07 Centro Nac De Investigaciones Cientificas Mezcla de compuestos con altos pesos moleculares, obtenida a partir de la cera de caña de azúcar (saccharum officinarum l.)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5160207A (en) * 1974-11-22 1976-05-26 Dai Ichi Kogyo Seiyaku Co Ltd Shibosanto kokyuarukooruno bunriho
JPH0610146B2 (ja) * 1985-10-12 1994-02-09 住友精化株式会社 直鎖第１級脂肪族高級アルコ−ルの抽出法
DE69026496D1 (de) * 1989-10-13 1996-05-15 Neurofit Analoge von vitamin a und ihre verwendung, insbesondere als cytotrophische und cytoprotective substanzen sowie diese substanzen enthaltende arzneimittel
CU22225A1 (es) * 1990-11-30 1995-01-31 Cent Nac Investig Scient Composicion farmacautica que contiene mezcla de alcoholes alifaticos primarios superiores para el tratamiento de hipercolesterolemia y la hiperlipoproteinemia tipo ii asi como estimulante de la conducta sexual en animales y humanos
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH06122892A (ja) * 1992-10-09 1994-05-06 Nippon Petrochem Co Ltd 粗ワックスの製造方法
CU22412A1 (es) * 1993-11-09 1996-01-31 Dalmer Lab Sa Una mezcla natural compuesta por alcoholes alifaticos primarios superiores obtenidos de la cera de abejas para el tratamiento de las ulceras gastricas y duodenales que presenta tambien actividad antiinflamatoria
US5554379A (en) * 1994-06-20 1996-09-10 Kv Pharmaceutical Company Long acting GI and esophageal protectant
JP2804445B2 (ja) * 1994-11-30 1998-09-24 ラボラトリオス ダルマー ソシエダッド アノニマ 胃潰瘍および十二指腸潰瘍の処置剤および抗炎症剤
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6080787A (en) * 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
AUPO605097A0 (en) * 1997-04-07 1997-05-01 James Cook University Of North Queensland Food grade wax and process for preparing same

Also Published As

Publication number Publication date
ZA982744B (en) 1998-10-08
DE69811643D1 (de) 2003-04-03
EP0969827B1 (en) 2003-02-26
WO1998043631A1 (en) 1998-10-08
AR016054A1 (es) 2001-06-20
CN1258218A (zh) 2000-06-28
JP4907750B2 (ja) 2012-04-04
ATE233087T1 (de) 2003-03-15
RU2217130C2 (ru) 2003-11-27
AU7349498A (en) 1998-10-22
BR9808470A (pt) 2000-05-23
CA2285242C (en) 2008-12-16
US6486205B2 (en) 2002-11-26
CN1230158C (zh) 2005-12-07
EP0969827A1 (en) 2000-01-12
CO4940484A1 (es) 2000-07-24
DE69811643T2 (de) 2003-12-24
HK1029054A1 (en) 2001-03-23
CU22723A1 (es) 2002-02-28
CA2285242A1 (en) 1998-10-08
DK0969827T3 (da) 2003-06-16
US20020058705A1 (en) 2002-05-16
JP2001518092A (ja) 2001-10-09
AU732045B2 (en) 2001-04-12
ES2192769T3 (es) 2003-10-16
MY120318A (en) 2005-10-31
JP2012067119A (ja) 2012-04-05

Similar Documents

Publication Publication Date Title
PT969827E (pt) Mistura de acidos gordos primarios obtida a partir de cera de cana de acucar
PL331700A1 (en) Method of obtaining fatty acid esters
PL342512A1 (en) Method of obtaining a fatty mixture
HUP0001295A1 (en) Methods and compositions for synthesis of long chain polyunsaturated fatty acids
HUP0001236A1 (en) Methods and compositions for synthesis of long chain polyunsaturated fatty acids
DE122011100027I1 (de) Wassrige suspension von 9-hydroxyrisperidon-fettsaureester.
AU1808295A (en) Hydrogenation of unsaturated fats, fatty acids or fatty acid esters
AU1792699A (en) Formation of conjugated unsaturated fatty acids
AU1444500A (en) Synthesis of conjugated polyunsaturated fatty acids
DE59810616D1 (de) Verfahren zur Herstellung von Saccharosefettsäureestern
EE9900541A (et) Toiduhappe tootmine
AU3543097A (en) Process for preparation of branched fatty acids
AR002119A1 (es) Procedimiento para preparar n-fosfonome-tilglicinaa partir de ácido n-fosfonometili-minodiacetico
BR9601310A (pt) Processo para a preparação de um álcool graxo a partir de uma mistura inicial líquida
ID18008A (id) Proses pembuatan bahan sabun
GB9620248D0 (en) Esters of unsaturated fatty acids
GB9930026D0 (en) Novel compounds of unsaturated fatty acids
ZA981668B (en) Presentation of fatty acids
IL122919A (en) Preparation of 1-alkyl-pyrazole-5- carboxylic acid esters
HUP9801996A3 (en) Fractionation of triglyceride oils
GB9621293D0 (en) Formulations containing unsaturated fatty acids
ZA98872B (en) Fractionation of triglyceride fats.
DK0931051T3 (da) Fremgangsmåde til fremstilling af fedtsyreestere
GB9828268D0 (en) Novel compounds of unsaturated fatty acids
GB9726247D0 (en) Preparation of esters